ficusin has been researched along with Lung Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, MK; Chiou, HL; Hsieh, MJ; Sheu, GT; Yu, YY | 1 |
| Cates, LA; Li, VS; Powell, DR; van der Helm, D | 1 |
2 other study(ies) available for ficusin and Lung Neoplasms
| Article | Year |
|---|---|
Psoralen reverses docetaxel-induced multidrug resistance in A549/D16 human lung cancer cells lines.
Topics: ATP Binding Cassette Transporter, Subfamily B; Cell Line, Tumor; Cell Proliferation; Docetaxel; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Ficusin; Humans; Lung Neoplasms; Taxoids | 2014 |
Phosphorus-nitrogen compounds. 24. Phosphoramide mustard carrier derivatives.
Topics: Animals; Diethylstilbestrol; Dosage Forms; Ficusin; Leukemia, Experimental; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Models, Molecular; Nitrogen Mustard Compounds; Propranolol; X-Ray Diffraction | 1984 |